254 related articles for article (PubMed ID: 20185164)
1. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter.
Arcangeli A; Rocca B; Salvatori G; Ciancia M; De Cristofaro R; Antonelli M
Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164
[TBL] [Abstract][Full Text] [Related]
2. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.
Nagarik AP; Soni SS; Adikey GK; Raman A
Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872
[TBL] [Abstract][Full Text] [Related]
4. Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial.
Garcés EO; Victorino JA; Thomé FS; Röhsig LM; Dornelles E; Louzada M; Stifft J; de Holanda F; Veronese FV
Ren Fail; 2010 Jan; 32(3):320-7. PubMed ID: 20370447
[TBL] [Abstract][Full Text] [Related]
5. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
[TBL] [Abstract][Full Text] [Related]
6. Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot study.
Fabbri LP; Nucera M; Al Malyan M; Becchi C
Acta Anaesthesiol Scand; 2010 Jan; 54(1):92-7. PubMed ID: 19650808
[TBL] [Abstract][Full Text] [Related]
7. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
8. Effects of dermatan sulfate for anticoagulation in continuous renal replacement therapy.
Vitale C; Verdecchia C; Bagnis C; Ganzaroli M; Giorcelli G; Marangella M
J Nephrol; 2008; 21(2):205-12. PubMed ID: 18446715
[TBL] [Abstract][Full Text] [Related]
9. Iloprost for additional anticoagulation in continuous renal replacement therapy--a pilot study.
Birnbaum J; Spies CD; Klotz E; Hein OV; Morgera S; Schink T; Ziemer S; Grund MS; Saalmann R; Kox WJ; Lehmann C
Ren Fail; 2007; 29(3):271-7. PubMed ID: 17497439
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
Langenecker SA; Felfernig M; Werba A; Mueller CM; Chiari A; Zimpfer M
Crit Care Med; 1994 Nov; 22(11):1774-81. PubMed ID: 7956281
[TBL] [Abstract][Full Text] [Related]
11. [Continuous venovenous hemodiafiltration in critically ill patients with acute renal failure].
Toft P; Felding M; Tønnesen EK
Ugeskr Laeger; 2000 May; 162(20):2868-71. PubMed ID: 10860424
[TBL] [Abstract][Full Text] [Related]
12. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
Chadha V; Garg U; Warady BA; Alon US
Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing haemodialysis.
Aggarwal A; Whitaker DA; Rimmer JM; Solomon RJ; Gennari FJ; Sobel BE; Schneider DJ
Nephrol Dial Transplant; 2004 Jun; 19(6):1559-63. PubMed ID: 15034156
[TBL] [Abstract][Full Text] [Related]
15. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis.
Gainza FJ; Quintanilla N; Pijoan JI; Delgado S; Urbizu JM; Lampreabe I
J Nephrol; 2006; 19(5):648-55. PubMed ID: 17136695
[TBL] [Abstract][Full Text] [Related]
16. Continuous venovenous hemodiafiltration versus hemodialysis as renal replacement therapy in patients with acute renal failure in the intensive care unit.
Chang JW; Yang WS; Seo JW; Lee JS; Lee SK; Park SK
Scand J Urol Nephrol; 2004; 38(5):417-21. PubMed ID: 15764254
[TBL] [Abstract][Full Text] [Related]
17. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
de Pont AC; Bouman CS; Bakhtiari K; Schaap MC; Nieuwland R; Sturk A; Hutten BA; de Jonge E; Vroom MB; Meijers JC; Büller HR
ASAIO J; 2006; 52(4):416-22. PubMed ID: 16883122
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system.
Tan HK; Yang WS; Chow P; Lui HF; Choong HL; Wong KS
Artif Organs; 2007 Mar; 31(3):193-9. PubMed ID: 17343694
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for continuous renal replacement therapy.
Tolwani AJ; Wille KM
Semin Dial; 2009; 22(2):141-5. PubMed ID: 19426417
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure.
Stefanidis I; Hägel J; Frank D; Maurin N
Clin Nephrol; 1996 Sep; 46(3):199-205. PubMed ID: 8879856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
